A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1997
11/13/1997	DE19618797A1 Vehikel zum Transport molekularer Substanz Vehicle for the transport of molecular substance
11/13/1997	DE19618727A1 Herstellung alkylierter Nucleosid-3'-Phosphate Preparation of alkylated nucleoside-3'-phosphates
11/13/1997	CA2253930A1 Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones
11/13/1997	CA2253919A1 Reparation and prevention of fibrotic lesions
11/13/1997	CA2253913A1 Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
11/13/1997	CA2253908A1 Stimulation of host defence mechanisms against tumors
11/13/1997	CA2253904A1 Targeted combination immunotherapy of cancer
11/13/1997	CA2253902A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	CA2253864A1 Neurotactin and uses therefor
11/13/1997	CA2253860A1 Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient
11/13/1997	CA2253858A1 Benzothiophenes, formulations containing same, and methods
11/13/1997	CA2253857A1 Anti-viral compounds
11/13/1997	CA2253834A1 B. burgdorferi polypeptides expressed in vivo
11/13/1997	CA2253803A1 Use of interleukin-10 to produce a population of suppressor cells
11/13/1997	CA2253788A1 Substituted imidazolium salts and their use for the inhibition of protein ageing
11/13/1997	CA2253751A1 Improvement of implantation rates after in vitro fertilization
11/13/1997	CA2253743A1 Anti-viral method
11/13/1997	CA2253742A1 Anti-viral compounds
11/13/1997	CA2253739A1 Anti-viral compounds
11/13/1997	CA2253597A1 Mixed chimerism and tolerance
11/13/1997	CA2253561A1 Cationic virosomes as transfer system for genetic material
11/13/1997	CA2253557A1 Treatment of asthma with tnfr-ig
11/13/1997	CA2253502A1 Anti-viral compounds
11/13/1997	CA2253473A1 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
11/13/1997	CA2253451A1 3-descladinose-2,3-anhydroerythromycin derivatives
11/13/1997	CA2253441A1 Glycoprotein hormone superagonists
11/13/1997	CA2253405A1 Anti-viral compounds
11/13/1997	CA2253401A1 Anti-viral compounds
11/13/1997	CA2253398A1 Anti-viral compounds
11/13/1997	CA2253390A1 Enhancement of sleep with a growth hormone secretagogue
11/13/1997	CA2253312A1 Method for treating inflammation
11/13/1997	CA2253284A1 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-¬2-(pyrrolidin-1-yl)ethoxy\|-phenyl}chromane, hyrogen fumarate
11/13/1997	CA2253260A1 Suspension of sparingly water-soluble acidic drug
11/13/1997	CA2251969A1 Composition comprising a katp channel inhibitor for use in the treatment of hemorrhagic shock
11/13/1997	CA2251129A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides
11/13/1997	CA2250579A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
11/13/1997	CA2226348A1 Ophthalmic preparations
11/13/1997	CA2205121A1 Antiadhesive properties of polyacrylic acids and polymethacrylic acids
11/13/1997	CA2204846A1 Pharmaceutical compounds
11/13/1997	CA2204704A1 Cosmetic composition with long chain unsaturated retinol fatty acid esters
11/13/1997	CA2204067A1 Chlorhexidine glucomate-containing, stabilized aqueous pharmaceutical preparations
11/12/1997	EP0806426A1 Process for the preparation of clavulanic acid
11/12/1997	EP0806423A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
11/12/1997	EP0806422A2 Anti-cataract agent
11/12/1997	EP0806420A1 Benzothiophenes, formulations containing same, and methods
11/12/1997	EP0806419A1 Benzoxazole derivatives as serotonin 5-HT3 receptor partial activator
11/12/1997	EP0806418A2 Novel pyrimidine compound and anti-rotavirus agent
11/12/1997	EP0806416A1 Huperzine a derivatives, their preparation and their use
11/12/1997	EP0806411A2 Anti-viral compounds
11/12/1997	EP0806410A2 Anti-viral compounds
11/12/1997	EP0806409A1 Anti-viral compounds
11/12/1997	EP0806408A1 Anti-viral compounds
11/12/1997	EP0806206A1 Aqueous compositions containing ciprofloxacine, and related use and process
11/12/1997	EP0806205A2 Urea, thiourea and guanidine compounds and their use as anti-viral agents
11/12/1997	EP0806204A1 Inflammatory cytokine production inhibitor containing polyprenyl derivative as active ingredient
11/12/1997	EP0806203A2 Anti-viral compositions
11/12/1997	EP0806140A1 Taxol composition for use as organ preservation and cardioplegic agents
11/12/1997	EP0805858A2 Inhibition of neovascularization using vegf-specific oligonucleotides
11/12/1997	EP0805853A1 Lineage-directed induction of human mesenchymal stem cell differentiation
11/12/1997	EP0805818A1 Novel peptides, their production and use
11/12/1997	EP0805817A1 Thiol derivatives with metallopeptidase inhibitory activity
11/12/1997	EP0805816A1 Compounds with growth hormone releasing properties
11/12/1997	EP0805815A1 Bismuth compounds
11/12/1997	EP0805813A1 Tricyclic vasopressin antagonists
11/12/1997	EP0805812A1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists
11/12/1997	EP0805810A1 Novel 9h-pyrido 3,4-b]indol derivatives
11/12/1997	EP0805809A2 Aza and aza (n-oxy) analogs of glycine/nmda receptor antagonists
11/12/1997	EP0805807A1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-(1)benzopyran for treating proliferative disorders
11/12/1997	EP0805806A1 Method for preparing 4,10-diacetoxy-2alfa-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxo-tax-11-en-13alfa-yl (2r,3s)-3-benzoylamino-2-hydroxy-3-phenylpropionate trihydrate
11/12/1997	EP0805802A1 Substituted phenyl compounds as endothelin antagonists
11/12/1997	EP0805796A1 Cell adhesion inhibitors
11/12/1997	EP0805795A1 Novel aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides
11/12/1997	EP0805790A1 Improved synthesis of cyclopropylacetylene
11/12/1997	EP0805688A1 Use of il-4 for potentiation of chemotherapeutic agents
11/12/1997	EP0805687A1 Recombinant human alpha-fetoprotein and uses thereof
11/12/1997	EP0805685A1 Novel antifungal cyclohexapeptides
11/12/1997	EP0805684A2 Methods of enhancing the therapeutic activity of nsaids and compositions of zwitterionic phospholipids useful therein
11/12/1997	EP0805683A1 5-carboxamido or 5-fluoro]- 2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/12/1997	EP0805682A1 Dermatological use of vitamin d derivatives
11/12/1997	EP0805680A2 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins
11/12/1997	EP0805679A1 Therapeutical use of beta-mimetic agents for the transmucosal treatment of dysmenorrhoea
11/12/1997	EP0805678A1 Surface-modified nanoparticles and method of making and using same
11/12/1997	EP0805677A1 Extended release clonidine formulation
11/12/1997	EP0805675A1 Directly compressible high load acetaminophen formulations
11/12/1997	EP0690850B1 2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists
11/12/1997	EP0659080A4 Method and composition for the treatment of hair loss.
11/12/1997	EP0605622B1 Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
11/12/1997	EP0605499B1 PROCESS FOR PREPARING ENANTIOMERICALLY PURE IMIDAZO 4,5,1-jk] 1,4]-BENZODIAZEPIN-2(1H -)-THIONES
11/12/1997	EP0600928B1 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it
11/12/1997	EP0600026B1 Cardiac output probe assembly
11/12/1997	CN1164856A Novel alkylamino derivatives as sigma 2 selective ligands
11/12/1997	CN1164855A Antiviral nucleoside analogues containing substituted benzimidazole base attached to carbocyclic ring
11/12/1997	CN1164537A New pseudopeptides derived from neurokinins, process for preparing them and pharmaceutical compositions contianing them
11/12/1997	CN1164533A Water-soluble anticancer compound-polyamino acid toxol ester
11/12/1997	CN1164531A Novel derivatives of 3-bromo-and 3,3-dibromo-4-oxo-1-azetidines, processes for preparation thereof and their use
11/12/1997	CN1164424A Controlled-release composition
11/12/1997	CN1164396A Ecological enema liquid for curing functional constipation
11/12/1997	CN1164392A Method for preparing compound tobramycin suspension for eye
11/12/1997	CN1164391A Hypopus nutrient weight-reducing oral liquor
11/12/1997	CN1164390A Amino acid metal chelate and its preparation and preparing method

1 ... 6725 6726 6727 6728 6729 6730 6731 6732 6733 6734 6735 6736 6737 6738 6739 6740 6741 6742 6743 6744 6745 ... 7860